ReP USP - Resultado da busca

Parte de monografia/livro
Biossegurança em laboratórios de biologia molecular e celular (2025)
Fajardo, Cristina Moreno ; Germano, Juliana de Freitas ; Nagai, Maria Aparecida
Fonte: Manual de Biossegurança. Unidades: FCF, FM
Assuntos: BIOSSEGURANÇA, LABORATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno e GERMANO, Juliana de Freitas e NAGAI, Maria Aparecida. Biossegurança em laboratórios de biologia molecular e celular. Manual de Biossegurança. Tradução . Barueri: Manole, 2025. . . Acesso em: 01 dez. 2025.
APA
Fajardo, C. M., Germano, J. de F., & Nagai, M. A. (2025). Biossegurança em laboratórios de biologia molecular e celular. In Manual de Biossegurança. Barueri: Manole.
NLM
Fajardo CM, Germano J de F, Nagai MA. Biossegurança em laboratórios de biologia molecular e celular. In: Manual de Biossegurança. Barueri: Manole; 2025. [citado 2025 dez. 01 ]
Vancouver
Fajardo CM, Germano J de F, Nagai MA. Biossegurança em laboratórios de biologia molecular e celular. In: Manual de Biossegurança. Barueri: Manole; 2025. [citado 2025 dez. 01 ]
Artigo de periodico-carta/editorial
PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer (2024)
Baldavira, Camila Machado; Prieto, Tabatha Gutierrez; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Fonte: Translational lung cancer research. Unidade: FM
Assuntos: NEOPLASIAS PULMONARES, METÁSTASE NEOPLÁSICA, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDAVIRA, Camila Machado et al. PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer. Translational lung cancer research. Shatin: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76895. Acesso em: 01 dez. 2025. , 2024
APA
Baldavira, C. M., Prieto, T. G., Nagai, M. A., & Capelozzi, V. L. (2024). PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer. Translational lung cancer research. Shatin: Faculdade de Medicina, Universidade de São Paulo. doi:10.21037/tlcr-23-734
NLM
Baldavira CM, Prieto TG, Nagai MA, Capelozzi VL. PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer [Internet]. Translational lung cancer research. 2024 ; 13( 1): 199-204.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76895
Vancouver
Baldavira CM, Prieto TG, Nagai MA, Capelozzi VL. PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer [Internet]. Translational lung cancer research. 2024 ; 13( 1): 199-204.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76895
Artigo de periodico
Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation (2023)
Souza, Manasses Soares; Sanvicente-Vieira, Breno; Zaparte, Aline; Baptista, Talita; Nagai, Maria Aparecida ; Mangone, Flavia Rotea; Pavanelli, Ana Carolina; Viola, Thiago Wendt; Grassi-oliveira, Rodrigo
Fonte: Neuroscience letters. Unidade: FM
Assuntos: RECEPTORES DE NEUROTRANSMISSORES, OCITOCINA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Manasses Soares et al. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation. Neuroscience letters, v. 816, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57385. Acesso em: 01 dez. 2025.
APA
Souza, M. S., Sanvicente-Vieira, B., Zaparte, A., Baptista, T., Nagai, M. A., Mangone, F. R., et al. (2023). Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation. Neuroscience letters, 816. doi:10.1016/j.neulet.2023.137506
NLM
Souza MS, Sanvicente-Vieira B, Zaparte A, Baptista T, Nagai MA, Mangone FR, Pavanelli AC, Viola TW, Grassi-oliveira R. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation [Internet]. Neuroscience letters. 2023 ; 816[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57385
Vancouver
Souza MS, Sanvicente-Vieira B, Zaparte A, Baptista T, Nagai MA, Mangone FR, Pavanelli AC, Viola TW, Grassi-oliveira R. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation [Internet]. Neuroscience letters. 2023 ; 816[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57385
Artigo de periodico
Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts (2023)
Telles, Guilherme Defante; Libardi, Cleiton Augusto ; Conceição, Miguel Soares ; Vechin, Felipe Cassaro ; Lixandrão, Manoel Emílio ; Mangone, Flavia Regina Rotea; Pavanelli, Ana Carolina; Nagai, Maria Aparecida ; Camera, Donny Michael; Hawley, John A; Ugrinowitsch, Carlos
Fonte: Medicine and Science in Sports and Exercise. Unidades: FM, EEFE
Assuntos: METILAÇÃO DE DNA, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA, EXERCÍCIO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELLES, Guilherme Defante et al. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts. Medicine and Science in Sports and Exercise, v. 55, n. 2, p. 199-208, 2023Tradução . . Disponível em: https://doi.org/10.1249/MSS.0000000000003049. Acesso em: 01 dez. 2025.
APA
Telles, G. D., Libardi, C. A., Conceição, M. S., Vechin, F. C., Lixandrão, M. E., Mangone, F. R. R., et al. (2023). Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts. Medicine and Science in Sports and Exercise, 55( 2), 199-208. doi:10.1249/MSS.0000000000003049
NLM
Telles GD, Libardi CA, Conceição MS, Vechin FC, Lixandrão ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts [Internet]. Medicine and Science in Sports and Exercise. 2023 ; 55( 2): 199-208.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1249/MSS.0000000000003049
Vancouver
Telles GD, Libardi CA, Conceição MS, Vechin FC, Lixandrão ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts [Internet]. Medicine and Science in Sports and Exercise. 2023 ; 55( 2): 199-208.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1249/MSS.0000000000003049
Artigo de periodico
Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts (2023)
Telles, Guilherme Defante; Libardi, Cleiton Augusto; Conceicao, Miguel Soares; Vechin, Felipe Cassaro; Lixandrao, Manoel Emilio; Mangone, Flavia Regina Rotea; Pavanelli, Ana Carolina; Nagai, Maria Aparecida ; Camera, Donny Michael; Hawley, John A; Ugrinowitsch, Carlos
Fonte: Medicine & science in sports & exercise. Unidade: FM
Assuntos: EXERCÍCIOS DE RESISTÊNCIA MUSCULAR, PROLIFERAÇÃO CELULAR, METILAÇÃO DE DNA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELLES, Guilherme Defante et al. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts. Medicine & science in sports & exercise, v. 55, n. 2, p. 199-208, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52913. Acesso em: 01 dez. 2025.
APA
Telles, G. D., Libardi, C. A., Conceicao, M. S., Vechin, F. C., Lixandrao, M. E., Mangone, F. R. R., et al. (2023). Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts. Medicine & science in sports & exercise, 55( 2), 199-208. doi:10.1249/MSS.0000000000003049
NLM
Telles GD, Libardi CA, Conceicao MS, Vechin FC, Lixandrao ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts [Internet]. Medicine & science in sports & exercise. 2023 ; 55( 2): 199-208.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52913
Vancouver
Telles GD, Libardi CA, Conceicao MS, Vechin FC, Lixandrao ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts [Internet]. Medicine & science in sports & exercise. 2023 ; 55( 2): 199-208.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52913
Artigo de periodico
The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients (2022)
Llera, Andrea Sabina; Abdelhay, Eliana Saul Furquim Werneck; Artagaveytia, Nora; Daneri-Navarro, Adrian; Muller, Bettina; Velazquez, Carlos; Alcoba, Elsa B; Alonso, Isabel; Quinta, Daniela B. Alves da; Nagai, Maria Aparecida
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, RECIDIVA LOCAL DE NEOPLASIA, HETEROGENEIDADE, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LLERA, Andrea Sabina et al. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.835626. Acesso em: 01 dez. 2025.
APA
Llera, A. S., Abdelhay, E. S. F. W., Artagaveytia, N., Daneri-Navarro, A., Muller, B., Velazquez, C., et al. (2022). The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, 12. doi:10.3389/fonc.2022.835626
NLM
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Vancouver
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Artigo de periodico
Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women (2022)
Almeida, Liz Maria de; Cortes, Sandra; Vilensky, Marta; Valenzuela, Olivia; Cortes-Sanabria, Laura; Souza, Mirian de; Barbeito, Rafael Alonso; Abdelhay, Eliana; Artagaveytia, Nora; Nagai, Maria Aparecida
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, FATORES SOCIOECONÔMICOS, MULHERES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Liz Maria de et al. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.845527. Acesso em: 01 dez. 2025.
APA
Almeida, L. M. de, Cortes, S., Vilensky, M., Valenzuela, O., Cortes-Sanabria, L., Souza, M. de, et al. (2022). Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, 12. doi:10.3389/fonc.2022.845527
NLM
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Vancouver
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Parte de monografia/livro
Modulação da expressâo gênica e epignética (2022)
Santos, Nathalia Leal; Nagai, Maria Aparecida ; Furuya, Tatiane Katsue
Fonte: Oncologia - da molécula à clínica. Unidade: FM
Assuntos: NEOPLASIAS, EXPRESSÃO GÊNICA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Nathalia Leal e NAGAI, Maria Aparecida e FURUYA, Tatiane Katsue. Modulação da expressâo gênica e epignética. Oncologia - da molécula à clínica. Tradução . São Paulo: Editora dos Editores, 2022. . . Acesso em: 01 dez. 2025.
APA
Santos, N. L., Nagai, M. A., & Furuya, T. K. (2022). Modulação da expressâo gênica e epignética. In Oncologia - da molécula à clínica. São Paulo: Editora dos Editores.
NLM
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2025 dez. 01 ]
Vancouver
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2025 dez. 01 ]
Artigo de periodico
Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes (2022)
Pavanelli, Ana Carolina; Mangone, Flavia Rotea; Yoganathan, Piriya; Bessa, Simone Aparecida; Nonogaki, Suely; Osorio, Cynthia A. B. de Toledo; Andrade, Victor Piana de; Soares, Ibere Cauduro; Mello, Evandro Sobrosa de; Mulligan, Lois M.; Nagai, Maria Aparecida
Fonte: Breast cancer research and treatment. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVANELLI, Ana Carolina et al. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, v. 192, n. 1, p. 43-52, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10549-021-06452-9. Acesso em: 01 dez. 2025.
APA
Pavanelli, A. C., Mangone, F. R., Yoganathan, P., Bessa, S. A., Nonogaki, S., Osorio, C. A. B. de T., et al. (2022). Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, 192( 1), 43-52. doi:10.1007/s10549-021-06452-9
NLM
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Vancouver
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Artigo de periodico
Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort (2021)
Machado-Rugolo, Juliana; Prieto, Tabatha Gutierrez ; Fabro, Alexandre Todorovic ; Cuentas, Edwin Roger Parra; Sá, Vanessa Karen de ; Baldavira, Camila Machado ; Rainho, Cláudia Aparecida; Castelli, Erick da Cruz; Farhat, Cecilia; Takagaki, Teresa Yae; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Fonte: Pharmacogenomics and Personalized Medicine. Unidades: FMRP, FM
Assuntos: SEQUENCIAMENTO GENÉTICO, NEOPLASIAS PULMONARES, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, v. 14, p. 239-252, 2021Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S286717. Acesso em: 01 dez. 2025.
APA
Machado-Rugolo, J., Prieto, T. G., Fabro, A. T., Cuentas, E. R. P., Sá, V. K. de, Baldavira, C. M., et al. (2021). Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, 14, 239-252. doi:10.2147/PGPM.S286717
NLM
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2025 dez. 01 ] Available from: https://doi.org/10.2147/PGPM.S286717
Vancouver
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2025 dez. 01 ] Available from: https://doi.org/10.2147/PGPM.S286717
Artigo de periodico
Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension (2021)
Fabro, Alexandre Todorovic ; Machado-Rugolo, Juliana ; Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez ; Farhat, Cecilia; Mangone, Flavia Regina Rotea; Batah, Sabrina Setembre ; Cruvinel, Heloísa Resende; Alda, Maiara Almeida; Monteiro, Jhonatas Sirino ; Padua, Adriana Inácio de; Morais, Sirlei Siani; Oliveira, Rogério Antônio de ; Santos, Marcel Koenigkam ; Martinez, José Antônio Baddini ; Setubal, João Carlos ; Rainho, Cláudia Aparecida ; Yoo, Hugo Hyung Bok ; Silva, Pedro Leme; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Fonte: Frontiers in Pharmacology. Unidades: FMRP, IQ, FM, Interunidades em Bioinformática
Assuntos: MICRORNAS, SEQUENCIAMENTO GENÉTICO, PLASMA, HIPERTENSÃO PULMONAR, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRO, Alexandre Todorovic et al. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, v. 12, p. 1-12 art. 648769, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.648769. Acesso em: 01 dez. 2025.
APA
Fabro, A. T., Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Farhat, C., Mangone, F. R. R., et al. (2021). Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, 12, 1-12 art. 648769. doi:10.3389/fphar.2021.648769
NLM
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Vancouver
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2025 dez. 01 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Artigo de periodico
In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors (2020)
Bastos, Daniel Rodrigues de; Nagai, Maria Aparecida
Fonte: PLOS ONE. Unidade: FM
Assuntos: OLIGOPEPTÍDEOS, PROGNÓSTICO, PACIENTES, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Daniel Rodrigues de e NAGAI, Maria Aparecida. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLOS ONE, v. 15, n. 5, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0232284. Acesso em: 01 dez. 2025.
APA
Bastos, D. R. de, & Nagai, M. A. (2020). In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLOS ONE, 15( 5). doi:10.1371/journal.pone.0232284
NLM
Bastos DR de, Nagai MA. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors [Internet]. PLOS ONE. 2020 ; 15( 5):[citado 2025 dez. 01 ] Available from: https://doi.org/10.1371/journal.pone.0232284
Vancouver
Bastos DR de, Nagai MA. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors [Internet]. PLOS ONE. 2020 ; 15( 5):[citado 2025 dez. 01 ] Available from: https://doi.org/10.1371/journal.pone.0232284
Artigo de periodico
Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer (2020)
Parra, Edwin Roger; Jiang, Mei; Machado-rugolo, Juliana; Yaegashi, Lygia Bertalha; Prieto, Tabatha; Farhat, Cecília; Sá, Vanessa Karen de; Nagai, Maria Aparecida ; Lima, Vladmir Cláudio Cordeiro de; Takagaki, Teresa Yae; Terra, Ricardo Mingarini ; Fabro, Alexandre Todorovic ; Capelozzi, Vera Luiza
Fonte: Archives of Pathology & Laboratory Medicine. Unidades: FM, FMRP, FSP
Assuntos: ANTÍGENOS, CARCINOMA, PULMÃO, NEOPLASIAS PULMONARES, LINFÓCITOS, IMUNOLOGIA, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Edwin Roger et al. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, v. 144, n. 10, p. 1234-1244, 2020Tradução . . Disponível em: https://doi.org/10.5858/arpa.2019-0419-OA. Acesso em: 01 dez. 2025.
APA
Parra, E. R., Jiang, M., Machado-rugolo, J., Yaegashi, L. B., Prieto, T., Farhat, C., et al. (2020). Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, 144( 10), 1234-1244. doi:10.5858/arpa.2019-0419-OA
NLM
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2025 dez. 01 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Vancouver
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2025 dez. 01 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Artigo de periodico
Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer (2019)
Machado-rugolo, Juliana; Fabro, Alexandre Todorovic ; Ascheri, Daniel; Farhat, Cecilia; Ab'saber, Alexandre Muxfeldt; Sa, Vanessa Karen de; Nagai, Maria Aparecida; Takagaki, Teresa; Terra, Ricardo; Parra, Edwin Roger; Capelozzi, Vera Luiza
Fonte: Human pathology. Unidades: FM, FMRP
Assuntos: NEOPLASIAS CEREBRAIS, METÁSTASE NEOPLÁSICA, NEOPLASIAS PULMONARES, IMUNOHISTOQUÍMICA, SEQUENCIAMENTO GENÉTICO, ONCOGENES, GENES SUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 01 dez. 2025.
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Artigo de periodico
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands (2018)
Carlini, Maria Jose; Nagai, Maria Aparecida; Recouvreix, Maria Sol; Simian, Marina
Fonte: Bmc cancer. Unidade: FM
Assuntos: RATOS, EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLINI, Maria Jose et al. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4550-z. Acesso em: 01 dez. 2025.
APA
Carlini, M. J., Nagai, M. A., Recouvreix, M. S., & Simian, M. (2018). Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, 18. doi:10.1186/s12885-018-4550-z
NLM
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2025 dez. 01 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
Vancouver
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2025 dez. 01 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
Artigo de periodico
Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) (2018)
Alcantara Filho, Paulo Roberto de; Mangone, Flavia Regina Rotea; Pavanelli, Ana Carolina; Garcia, Simone Aparecida de Bessa; Nonogaki, Suely; Andrade, Victor Piana de; Nagai, Maria Aparecida
Fonte: Breast cancer management. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, IMUNOHISTOQUÍMICA, PROTEÍNAS DO TECIDO CONJUNTIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCANTARA FILHO, Paulo Roberto de et al. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, v. 7, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.2217/bmt-2017-0019. Acesso em: 01 dez. 2025.
APA
Alcantara Filho, P. R. de, Mangone, F. R. R., Pavanelli, A. C., Garcia, S. A. de B., Nonogaki, S., Andrade, V. P. de, & Nagai, M. A. (2018). Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, 7( 2). doi:10.2217/bmt-2017-0019
NLM
Alcantara Filho PR de, Mangone FRR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VP de, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2025 dez. 01 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Vancouver
Alcantara Filho PR de, Mangone FRR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VP de, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2025 dez. 01 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Artigo de periodico
PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells (2018)
Bonatto, Naieli; Carlini, Maria Jose; Garcia, Simone Aparecida de Bessa; Nagai, Maria Aparecida
Fonte: Cell adhesion & migration. Unidade: FM
Assuntos: NEOPLASIAS, EXPRESSÃO GÊNICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONATTO, Naieli et al. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, v. 12, n. 1, p. 37-46, 2018Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25547. Acesso em: 01 dez. 2025.
APA
Bonatto, N., Carlini, M. J., Garcia, S. A. de B., & Nagai, M. A. (2018). PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, 12( 1), 37-46. doi:10.1080/19336918.2017.1313382
NLM
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2025 dez. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
Vancouver
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2025 dez. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
Trabalho de evento-resumo periodico
Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients (2017)
Machado, Juliana; Nagai, Maria Aparecida; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
Fonte: Journal of thoracic oncology. Nome do evento: World conference on lun cancer - ASLC. Unidades: FM, FMRP
Assuntos: NEOPLASIAS PULMONARES, ADENOCARCINOMA, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 01 dez. 2025. , 2017
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2025 dez. 01 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2025 dez. 01 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity (2017)
Oliveira Filho, Lourival A.; Carlini, Maria José; Nagai, Maria Aparecida
Fonte: Cancer Research. Nome do evento: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy. Unidade: FM
Assuntos: APOPTOSE, BIOMARCADORES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA FILHO, Lourival A. e CARLINI, Maria José e NAGAI, Maria Aparecida. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445. Acesso em: 01 dez. 2025. , 2017
APA
Oliveira Filho, L. A., Carlini, M. J., & Nagai, M. A. (2017). Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445
NLM
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2025 dez. 01 ] Available from: https://doi.org/10.1158/1538-7445
Vancouver
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2025 dez. 01 ] Available from: https://doi.org/10.1158/1538-7445
Artigo de periodico
Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity (2017)
Garcia, Simone Aparecida de Bessa; Pavanelli, Ana Carolina; Melo, Natália Cruz e; Nagai, Maria Aparecida
Fonte: International Journal of Molecular Medicine. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, BIOMARCADORES, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Simone Aparecida de Bessa et al. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, v. 39, n. 4, p. 809-818, 2017Tradução . . Disponível em: https://doi.org/10.3892/ijmm.2017.2900. Acesso em: 01 dez. 2025.
APA
Garcia, S. A. de B., Pavanelli, A. C., Melo, N. C. e, & Nagai, M. A. (2017). Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, 39( 4), 809-818. doi:10.3892/ijmm.2017.2900
NLM
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2025 dez. 01 ] Available from: https://doi.org/10.3892/ijmm.2017.2900
Vancouver
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2025 dez. 01 ] Available from: https://doi.org/10.3892/ijmm.2017.2900

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada